Redeye takes a positive stance towards the partial divestment of Aspire.
Redeye expects a stable Q2 report from Lagercrantz with muted organic growth yet solid margins.
Förvärvet av TrustPlay, med tillhörande teknikportfölj, positionerar Tangiamo i framkant av den växa...
Redeye lowers its forecasts for Q3 and 2024 somewhat on the back of a slightly softer outlook in Nor...
Redeye offers a preview of Doro's Q3 results set to be released on October 25.
We cut '24e-'26e EBITA by 21-4%... ...due to weaker IT consulting market data '25e EV/EBITA of ~7x ...
Minor near-term estimate cuts following the cyberattack Outlook for order intake unchanged NTM EV/EB...
We trim '24e-'26e ARR by 1% on continued macro weakness Still awaiting a return in B2C business mome...
Solid Q3e with 7% organic growth and 22% EBITDA growth US market could be sluggish again, but focus ...
STENOCARE announced on October 14th that the company has updated the sales guidance for 2024, from g...
Redeye expects a stable Q3 report from Addnode with limited growth yet solid margins.
Redeye has a positive view on the news from this morning, announcing that Saniona's collaboration wi...
Redeye comments on Truecaller ahead of its Q3 results, which are due on 7 November.
Lumi Gruppen announced a trading update today for the school year 2024-25.
VIMAB Group är en industrikoncern verksamt inom miljö, elektrifiering och near-shoring.
Redeye shares its preview of BONESUPPORT’s Q3 2024 results, due October 24.
Redeye gives its preview on OssDsign’s Q3 2024 report, due on November 5.
Redeye presents its preview for Devyser’s Q3 2024 report, due on October 30.
• Q3: EBITDA of ~NOK 10m • New targets achievable, but lower range more likely • Recovery postponed ...
MoveByBike Europe AB ("MoveByBike" eller ”Bolaget”) meddelade den 10 oktober 2024 att Airmee blir en...
